C07D 261/08
With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to
Official title: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
C07D261/08 (With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to) appears on 1,166 US grants and 1,041 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,166
- Published applications
- 1,041
- Assignees
- 549
- Inventors
- 3,835
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 14 | 0 |
| 1977 | 21 | 0 |
| 1978 | 16 | 0 |
| 1979 | 9 | 0 |
| 1980 | 21 | 0 |
| 1981 | 16 | 0 |
| 1982 | 10 | 0 |
| 1983 | 12 | 0 |
| 1984 | 9 | 0 |
| 1985 | 10 | 0 |
| 1986 | 6 | 0 |
| 1987 | 7 | 0 |
| 1988 | 8 | 0 |
| 1989 | 14 | 0 |
| 1990 | 12 | 0 |
| 1991 | 17 | 0 |
| 1992 | 6 | 0 |
| 1993 | 18 | 0 |
| 1994 | 22 | 0 |
| 1995 | 21 | 0 |
| 1996 | 33 | 0 |
| 1997 | 35 | 0 |
| 1998 | 20 | 0 |
| 1999 | 35 | 0 |
| 2000 | 22 | 0 |
| 2001 | 29 | 5 |
| 2002 | 27 | 27 |
| 2003 | 25 | 46 |
| 2004 | 19 | 59 |
| 2005 | 21 | 57 |
| 2006 | 29 | 59 |
| 2007 | 28 | 51 |
| 2008 | 30 | 52 |
| 2009 | 29 | 58 |
| 2010 | 40 | 57 |
| 2011 | 31 | 45 |
| 2012 | 44 | 41 |
| 2013 | 36 | 35 |
| 2014 | 45 | 43 |
| 2015 | 32 | 44 |
| 2016 | 29 | 35 |
| 2017 | 43 | 51 |
| 2018 | 41 | 35 |
| 2019 | 27 | 34 |
| 2020 | 28 | 41 |
| 2021 | 29 | 40 |
| 2022 | 27 | 35 |
| 2023 | 21 | 35 |
| 2024 | 13 | 26 |
| 2025 | 17 | 19 |
| 2026 | 12 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- PAI-1 inhibitors and uses thereof15 Sep 2026US 12,735,402 B2The Cleveland Clinic Foundation
- Phenyl-sulfamoyl-benzoic acid derivatives as ERAP1-modulators28 Jul 2026US 12,692,223 B2Grey Wolf Therapeutics Limited
- Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof26 May 2026US 12,637,436 B2Sanford Burnham Prebys Medical Discovery Institute
- Cyclic amine derivatives having serotonin receptor binding activity26 May 2026US 12,637,443 B2Shionogi & Co., Ltd.
- Tetraline, phenylcyclobutane and phenylcyclopentane analogs as rxfp1 agonists10 Sep 2026US 2026/0265208 A1Bristol-Myers Squibb Company
- Pai-1 inhibitors and uses thereof20 Aug 2026US 2026/0242355 A1The Cleveland Clinic Foundation
- Neutrophil elastase inhibitor and use thereof16 Jul 2026US 2026/0200845 A1Shanghai Yidi Biotechnology Co., Ltd
- Novel Processes for Preparation of Soluble Guanylate Cyclase Stimulators18 Jun 2026US 2026/0167634 A1Cyclerion Therapeutics, Inc.
- Synthesis of bromodomain inhibitors23 Apr 2026US 2026/0109710 A1Constellation Pharmaceuticals, Inc.
Most cited
By later US patents
- Prostaglandin synthase inhibitors169US 5,593,994 AThe DuPont Merck Pharmaceutical Company · 1997
- Cell differentiation inducer110US 6,174,905 B1Mitsui Chemicals, Inc. · 2001
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Substituted isoxazoles for the treatment of inflammation102US 5,633,272 A1997
- Pharmacologically active guanidine compounds97US 3,950,333 ASmith Kline & French Laboratories Limited · 1976